Mark Christopher Capone serves as Executive at MYRIAD GENETICS INC, where they oversee executive responsibilities. Since joining the company, Mark Christopher Capone has executed 115 insider transactions totaling $31.2M, demonstrating a bearish approach to their equity position. Their most recent transaction on Aug 29, 2008 involved exercising options for 3,000 shares valued at $50.9K.
Mark Christopher Capone currently holds 2,128 shares of MYRIAD GENETICS INC (MYGN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark Christopher Capone has been a net seller of MYGN stock. They have purchased $212.4K and sold $31.0M worth of shares.
Mark Christopher Capone's most recent insider trade was on Aug 29, 2008, when they sold 3,000 shares at $16.97 per share.
Get notified when new Form 4 filings are submitted
| 100 |
| $15.28 |
| Discretionary |
| Aug 7, 2007 | MYGN | $4.3K | Sale | 100 | $43.03 | Discretionary |
| Aug 7, 2007 | MYGN | $3.1K | Option Exercise | 200 | $15.28 | Discretionary |
| Aug 7, 2007 | MYGN | $8.6K | Sale | 200 | $43.01 | Discretionary |
| Aug 7, 2007 | MYGN | $62.2K | Option Exercise | 4,073 | $15.28 | Discretionary |
| Aug 7, 2007 | MYGN | $175.1K | Sale | 4,073 | $43.00 | Discretionary |
| Aug 7, 2007 | MYGN | $3.1K | Option Exercise | 200 | $15.28 | Discretionary |
| Aug 7, 2007 | MYGN | $8.6K | Sale | 200 | $43.07 | Discretionary |
| Aug 7, 2007 | MYGN | $1.5K | Option Exercise | 100 | $15.28 | Discretionary |
| Aug 7, 2007 | MYGN | $1.5K | Option Exercise | 100 | $15.28 | Discretionary |
| Aug 7, 2007 | MYGN | $4.3K | Sale | 100 | $43.04 | Discretionary |
| Aug 7, 2007 | MYGN | $4.3K | Sale | 100 | $43.06 | Discretionary |
| Mar 23, 2007 | MYGN | $17.0K | Option Exercise | 1,000 | $16.97 | Discretionary |
| Mar 23, 2007 | MYGN | $55.1K | Option Exercise | 4,400 | $12.53 | Discretionary |